Globe Life Inc. (GL)
NYSE: GL
· Real-Time Price · USD
120.34
0.55 (0.46%)
At close: Jun 16, 2025, 3:59 PM
119.79
-0.46%
After-hours: Jun 16, 2025, 07:48 PM EDT
Globe Life Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Segment Revenue | 1.4B | 1.32B | 1.28B | 1.2B | 1.14B | 1.08B | 1.02B | 976.37M | 947.66M | 925.52M | 869.44M | 1.16B | 1.05B | 930.49M |
| Health Segment Revenue Growth | +6.53% | +3.08% | +6.47% | +5.31% | +5.92% | +6.11% | +3.99% | +3.03% | +2.39% | +6.45% | -25.29% | +11.08% | +12.61% | n/a |
| Life Segment Revenue | 3.26B | 3.14B | 3.02B | 2.9B | 2.67B | 2.52B | 2.41B | 2.31B | 2.19B | 2.07B | 1.97B | 1.89B | 1.81B | 1.73B |
| Life Segment Revenue Growth | +3.96% | +3.77% | +4.32% | +8.43% | +6.16% | +4.62% | +4.34% | +5.35% | +5.61% | +5.43% | +4.29% | +4.25% | +4.77% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 105.7M | 99.77M | n/a | 10.09M | 89.68M | 85.21M | 7.57M | 7.49M | 81.59M | 87.08M | 9.12M | 8.45M | 81.6M | 75.89M | 7.78M | 8.36M | 74.06M | 71.99M | 72.39M | 70.2M | 72.98M | 78.41M | 74.58M | 79.04M | 73M | 70M | 74M | 69M | 67M | 69M | 63M | 62M | 62M | 59M | 58M | 58M | 55.4M | 50.15M | 57.78M | 56.98M | 54.44M |
| Selling, General, and Administrative Revenue Growth | +5.94% | n/a | -100.00% | -88.75% | +5.24% | +1026.13% | +1.08% | -90.82% | -6.30% | +854.77% | +7.95% | -89.65% | +7.52% | +875.95% | -7.03% | -88.71% | +2.88% | -0.55% | +3.12% | -3.81% | -6.93% | +5.15% | -5.65% | +8.28% | +4.29% | -5.41% | +7.25% | +2.99% | -2.90% | +9.52% | +1.61% | 0.00% | +5.08% | +1.72% | 0.00% | +4.69% | +10.48% | -13.21% | +1.41% | +4.66% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |